Pharmaceutical

Mr Jaynil Doshi, Director – Techno Commercial, Pioma Ch...

FDD Conclave: Mumbai Connect | 6th March 2026 The post Mr Jaynil Doshi, Directo...

BIRAC fuels innovation with Rs. 4,200 crore funding acr...

Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Ent...

Congruence secures $39.5m to advance small molecule cor...

The portfolio includes programmes targeting melanocortin 4 receptor (MC4R)-defic...

Novartis to acquire SNV4818 from Synnovation

Under the contract, Novartis will pay $2bn upfront and up to $1bn in milestones ...

Eris launches weekly shot of Semaglutide starting at ₹2...

Eris Lifesciences, a leading Indian branded formulations company, today announc...

Lupin Manufacturing Solutions announces expansion of ma...

Lupin Manufacturing Solutions (LMS), a global CRDMO and subsidiary of global ph...

Zydus launches Aerolife Mini, to simplify inhaler use f...

Zydus Lifesciences, an innovation-led life-sciences company with an internation...

Glenmark Pharmaceuticals USA launches authorised generi...

Glenmark Pharmaceuticals USA announces the launch of Milnacipran Hydrochloride ...

Partners in progress: PPL 2026 

PPL 2026 brought together India’s pharma packaging ecosystem to explore how col...

R1 Therapeutics raises $77.5m to progress AP306 for hyp...

The company also secured an exclusive global licence for the development and com...

FDA issues CRL to Aldeyra’s reproxalap drug application

This CRL stated that the application lacks substantial evidence of efficacy from...

Zydus and Torrent Pharma sign licensing agreement to co...

Zydus Lifesciences, an innovation-led global life-sciences company and Torrent ...

CPHI Middle East and BIO Middle East set to position Sa...

CPHI Middle East and BIO Middle East are set to position Saudi Arabia at the fo...

Akums launches first-of-its-kind Lasmiditan dispersible...

Akums Drugs & Pharmaceuticals has announced the launch of the world’s first Las...

Strides strengthens its Africa business with acquisitio...

Strides Pharma Science announced that its step‑down subsidiary, Strides Pharma ...

India’s upcoming semaglutide boom: A turning point for ...

With semaglutide’s Indian patent set to expire on March 20, 2026, domestic drug...